Bain Capital acquires Vitabiotics
Analysis based on 9 articles · First reported Jul 24, 2026 · Last updated Jul 24, 2026
The acquisition signals strong private equity interest in the nutraceutical sector, potentially boosting valuations for similar companies. Bain Capital's investment may enhance Vitabiotics' growth prospects in emerging markets, positively impacting its brand equity and market share.
Global private investment firm Bain Capital has agreed to acquire Vitabiotics, the UK's largest vitamin company, including its UK operations and the wider VB Group comprising Meyer Organics in India and operations across Africa, including VB Egypt. The financial details were not disclosed, but sources value the deal at $850 million to $1.2 billion. The acquisition aims to accelerate Vitabiotics' international expansion, with Bain Capital's Asia Private Equity team leading the investment. Vitabiotics will remain headquartered in the UK with no immediate operational changes. Founder Kartar Lalvani will become Chairman Emeritus, while CEO Tej Lalvani continues to lead the company. The deal strengthens Bain Capital's presence in the global wellness sector amid growing demand for vitamins and supplements.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard